MORE►
dermatology
Senderra CEO and founder Will Howard [Composite image: DI Studio; Sources: Senderra, ilyaliren/istockphoto]
Dallas-Based SenderraRx Gets Growth Investment from Rhode Island’s Nautic Partners
by Sandra Engelland | Dec 13, 2025
Founded in 2010, SenderraRx said it has made a name for itself in the specialty pharmacy space by focusing on therapies for patients with complex and chronic conditions in areas such as dermatology, rheumatology, and oncology.
by David Seeley |
Jul 15, 2025
The California-based clinical-stage biotech startup is developing therapies to treat serious immunological diseases like atopic dermatitis and vitiligo.
MORE►
by Lance Murray |
Sep 22, 2023
Samuel Barone, M.D., is a former Federal Drug Administration official and leader in the pharmaceutical space.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
